Central venous catheter-related bloodstream infections in cancer patients

Journal of the College of Physicians and Surgeons Pakistan

Volumn 14, Issue 9, 2004, Pages 549-552

  Butt, Tariq ^b   Afzal, Raja Kamran ^b   Ahmad, Rifat Nadeem ^b   Hussain, Iftikhar ^a   Anwar, Masood ^b  

^a National University of Medical Sciences   (Pakistan)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (Pakistan)

Author keywords

Antimicrobial susceptibility; Bloodstream infection; Central venous catheter

Indexed keywords

AMIKACIN; AMPHOTERICIN B; AMPICILLIN; ANTIBIOTIC AGENT; CEFEPIME; CEFOTAXIME; CEFRADINE; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CLOXACILLIN; COTRIMOXAZOLE; DOXYCYCLINE; FLUCONAZOLE; FUSIDIC ACID; GENTAMICIN; IMIPENEM; ITRACONAZOLE; METICILLIN; MOXIFLOXACIN; OFLOXACIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TEICOPLANIN; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BLOOD SAMPLING; CANCER PATIENT; CANDIDA ALBICANS; CATHETER INFECTION; CENTRAL VENOUS CATHETERIZATION; CLINICAL STUDY; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; DEVICE REMOVAL; EPIDEMIOLOGICAL DATA; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE COCCI; HOSPITAL ADMISSION; HUMAN; INFECTION CONTROL; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PAKISTAN; PATHOGENESIS; PUBLIC HOSPITAL; QUANTITATIVE ANALYSIS; SCHOOL CHILD; SEROPREVALENCE; STANDARDIZATION;

ADOLESCENT; ADULT; AGED; BACTEREMIA; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CHILD; DRUG RESISTANCE, BACTERIAL; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PAKISTAN;

EID: 5044251893     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Melgrange VB, Escande MC, Theobald S. Validity of earlier positivity of central venous blood cultures in comparison with peripheral blood cultures for diagnosing catheter-related bacteremia in cancer patients. J Clin Microbiol 2001; 39: 274-8.
2. Rello J, Ochagavia A, Sabanes E, Roque M, Mariscal D, Reynaga E, et al. Evaluation of outcome of intravenous catheter-related infections in critically ill patients. Am J Respir Crit Care Med 2000; 162: 1027-30.
3. Nicastri E, Petrosillo N, Viale P, Ippolito G. Catheter-related bloodstream infections in HIV-infected patients. Ann NY Acad Sci 2001; 946: 274-90.
4. Garner JS. Guidelines for prevention of intravascular infections. The Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1996; 17: 53-80.
5. Coccaro M, Bochicchio AM, Capobianco AM, Dileo P, Mancino G, Cammarota A. Long-term infusional systems: complications in cancer patients. Tumori 2001; 87: 308-11.
6. Burney IA, Khurshaidi N, Akbar MT, Bhatti FN, Siddiqui T, Sophie Z. Complications of in-dwelling venous access devices: a single institution experience. J Pak Med Assoc 2001; 51: 434-7.
7. Nouwen JL, van Beikum A, de Marie S, Sluijs J, Wielenga JJ, Kluytmans JAJW, et al. Clonal expansion of Staphylococcus epidermidis strains causing Hickman catheter-related infections in a hematooncologic department. J Clin Microbiol 1998; 36: 2696-702.
8. Jarris WR. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 1995; 20: 1526-30.
9. Cleri DJ, Corrado ML, Seligman SJ. Quantitative culture of intravenous catheters and other intravascular inserts. J Infect Dis 1987; 141: 781-6.
10. Brun-Buisson C, Abrouk F, Legrand P, Huet Y, Larabi S, Rapin M. Diagnosis of central venous catheter-related sepsis. Critical level of quantitative tip cultures. Arch Intern Med 1987; 147: 873-7.
11. Raad II, Sabbagh MF, Rand KH, Sherertz RJ. Quantitative tip culture methods and the diagnosis of central venous catheter-related infections. Diagn Microbiol Infect Dis 1992; 15: 13-20.
12. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. 7th ed. Approved Standard M2-A7. Wayne, PA: The Committee; 2000.
13. Pfaller MA, Messer SA, Bolmstrom, Odds FC, Rex JH. Multisite reproducibility of the Etest MIC method for antifungal susceptibility testing of yeast isolates. J Clin Microbiol 1996; 34: 1691-3.
14. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1992-June 2001, issued August 2001. Am J Infect Control 2001; 29: 404-21.
15. National Nosocomial Infections Surveillance (NNIS) System report, data summary from October 1986-April 1998, issued June 1998. Am J Infect Control 1998; 26: 522-33.
16. Hafeez A, Mazhar F, Qureshi S, Ahmed K. Incidence of infection in peripheral intravenous cannulas. J Coll Physicians Surg Pak 2001; 11: 421-3.
17. Butt T, Zahur-ur-Rehman. Incidence of infection in peripheral intravenous cannulas. J Coll Physicians Surg Pak 2001; 11: 783-4.
18. Dobbins BM, Catton JA, Kite P, McMahon MJ, Wilcox MH. Each lumen is a potential source of central venous catheter-related bloodstream infection. Crit Care Med 2003; 31: 1688-90.
19. Seifert H, Cornely O, Seggewiss K, Decker M, Stefanik D, Wisplinghoff H, et al. Bloodstream infection in neutropenic cancer patients related to short-term nontunneled catheters determined by quantitative blood cultures, differential time to positivity, and molecular epidemiological typing with pulsed-field gel electrophoresis. J Clin Microbiol 2003; 41: 118-23.
20. Howell PB, Walters PE, Donowitz GR, Farr BM. Risk factors for infection of adult patients with cancer who have tunneled central venous catheters. Cancer 1995; 75: 1367-75.
21. Raad II, Costerton W, Sabharwal U, Sacilowski M, Anaissie E, Bodey GP. Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J Infect Dis 1993; 168: 400-7.
22. Oncu S, Ozsut H, Yildirim A, Ay P, Cakar N, Eraksoy H, et al. Central venous catheter related infections: risk factors and the effect of glycopeptide antibiotics. Ann Clin Microbiol Antimicrob 2003; 2: 3.
23. Zinner SH. Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on Gram-positive and resistant bacteria. Clin Infect Dis 1999; 29: 490-4.
24. Hughes WT, Armstrong D, Bodley GP, Bow EJ, Brown AE, Calandra T, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Infectious Diseases Society of America. Clin Infect Dis 2002; 34: 730-51.
25. Karamat KA, Tariq TM, Hanan A, Siddiqi MS, Bun T, Anwar M, et al. Bacterial infections in neutropenic cancer patients. Pak J Pathol 1998; 9: 38-43.